JUL 03, 2017 7:11 PM PDT

"Membrane Blebs" Render Pathogens Defenseless

WRITTEN BY: Kara Marker

The immune system recruits many different types of cells that specialize in ridding the body of pathogens like bacteria and viruses. These specialized cells usually work by either recognizing virally-infected cells or bacteria and then marking them for destruction. In a new study of “membrane blebs,” scientists reveal how small proteins lend a helping hand in the fight against pathogens.

The Bochum team: Dr Sergii Shydlovskyi, Dr Semra Ince and Prof Dr Christian Herrmann. Credit: Ruhr-Universität Bochum

What are membrane blebs?

Membrane blebs are small pouches produced by a cell to engulf and trap pathogens before delivering them to be destructed. In this way, cells contribute to the anti-viral or anti-bacteria attack in their own way. From Ruhr-University Bochum and a team of researchers, scientists looked inside the cell to figure out exactly how they were creating these membrane blebs.

The foundation of membrane bleb formation is all thanks to human guanylate-binding protein 1, or hGBP1, researchers found. These proteins “talk” to a molecule called GTP, which is capable of carrying energy for cells and their organelles to use for various tasks. In this case, the task is to trap viruses and bacteria so they can’t spread infection.

Next, hGBP1 uses energy via GTP to morph into a completely different structure. In their new form, the proteins are able to produce a “lipid anchor.” This product is called an anchor because it helps the newly-structured hGBP1 connect to other hGBP1 proteins, making a massive blob of proteins to become a membrane bleb, a vesicle to trap pathogens.

Pathogens are engulfed by and trapped in these vesicles, which transport the pathogens to cell organelles called lysosomes, which are capable of dissolving the bacteria and viruses for removal from the cell.

With the involvement of hGBP1 in the creation of membrane blebs now understood in more detail, researchers are more equipped to help the immune system protect the body from a wide array of dangerous pathogens. This study also leads to the asking of this question: can scientists create their own membrane blebs to fight infection?

The present study was published in the journal Proceedings of the National Academy of Sciences.

Sources: Ruhr-University Bochum, Cell Death & Differentiation, Journal of Microscopy

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 30, 2021
Immunology
The Body Makes Its Own Anti-inflammatory 'Cannabis' After a Workout
NOV 30, 2021
The Body Makes Its Own Anti-inflammatory 'Cannabis' After a Workout
Feeling great after hitting the gym? That’s because of the flood of endorphins released into the body after a bout ...
DEC 23, 2021
Immunology
Double Whammy Cytokine Hit Stops Transplant Side Effects
DEC 23, 2021
Double Whammy Cytokine Hit Stops Transplant Side Effects
  Patients who receive bone marrow or stem cell transplants are offered the gift of a new lease of life. However, s ...
JAN 01, 2022
Health & Medicine
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
JAN 01, 2022
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine ...
JAN 12, 2022
Health & Medicine
Should You Intentionally Get Omicron?
JAN 12, 2022
Should You Intentionally Get Omicron?
With the pandemic coming up on its 2-year anniversary, the ironic question more people are contemplating with this less ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
JAN 14, 2022
Health & Medicine
First Genetically-Altered Pig Heart Transplanted to a Human
JAN 14, 2022
First Genetically-Altered Pig Heart Transplanted to a Human
Doctors have performed the first successful transplantation of a pig heart into a human. David Bennett, a 57-year-old ma ...
Loading Comments...